Four pharma companies accused of 700% prochlorperazine price hike

Three manufacturers and a wholesaler broke the law by agreeing not to compete in the supply of anti-nausea drug prochlorperazine, a government watchdog has alleged.

CMA.jpg
The CMA’s findings are provisional and it has not yet made a final decision

Latest from News

More from Clinical